aana glp 1 guidelines Filipino American Nurse Anesthesiology Society | GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are changing the perioperative conversation. With evolving guidance, View of GLP-1 receptor agonists

Medication alone rarely addresses the underlying relationship patients have with food, control, distress, or self-image

GLP-1(28-36)amide, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP)

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Background In clinical trials enrolling patients with type 2 diabetes (T2D) at high cardiovascular risk, many glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improved albuminuria status and possibly mitigated kidney function loss

Important: This product is NOT a GLP-1 receptor agonist